Viemed Healthcare (VMD) Return on Capital Employed (2018 - 2026)

Viemed Healthcare's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 14.85% for Q1 2026.

• Quarterly Return on Capital Employed rose 110.0% year-over-year to 14.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.85% (up 110.0% YoY) and the FY2025 annual result came in at 15.61%, up 169.0% from the prior year.
• Return on Capital Employed was 14.85% for Q1 2026 at Viemed Healthcare, up from 14.37% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 14.85% in Q1 2026 and bottomed at 8.15% in Q1 2023.
• A 5-year average of 11.92% and a median of 11.97% in 2024 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 1344 bps — and 2023, when it surged 364 bps.
• Viemed Healthcare's Return on Capital Employed stood at 8.3% in 2022, then jumped by 44 bps to 11.94% in 2023, then gained by 10 bps to 13.16% in 2024, then increased by 9 bps to 14.37% in 2025, then advanced by 3 bps to 14.85% in 2026.
• Business Quant data shows VMD's Return on Capital Employed at 14.85% in Q1 2026, 14.37% in Q4 2025, and 14.09% in Q3 2025.